Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/19/2009WO2009140624A2 Glucokinase activators
11/19/2009WO2009140587A1 Pulmonary delivery of a fluoroquinolone
11/19/2009WO2009140575A1 Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
11/19/2009WO2009140557A2 Modified release tolterodine formulations
11/19/2009WO2009140553A2 Hypoxia activated drugs of nitrogen mustard alkylators
11/19/2009WO2009140549A1 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
11/19/2009WO2009140527A1 Modified release formulations of dihydropyridine compounds and methods of making same
11/19/2009WO2009140519A1 Compounds and compositions for treating chemical warfare agent-induced injuries
11/19/2009WO2009140517A1 Compounds and compositions for treating chemical warfare agent-induced injuries
11/19/2009WO2009140500A1 Hepatitis c virus inhibitors
11/19/2009WO2009140484A1 Processes for preparing amorphous drug substance
11/19/2009WO2009140483A1 Muscarinic agonists as cognitive enhancers
11/19/2009WO2009140479A1 Amorphous solid dispersions
11/19/2009WO2009140475A1 Hepatitis c virus inhibitors
11/19/2009WO2009140467A1 Oxobenzindolizinoquinolines and uses thereof
11/19/2009WO2009140464A1 Methods of administration of thrombopoietin mimetic compounds
11/19/2009WO2009140457A2 Combinations of antioxidants and anti-inflammatory drugs in the of treatment inflammatory bowel disease
11/19/2009WO2009140448A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators
11/19/2009WO2009140447A1 Immunomodulation by iap inhibitors
11/19/2009WO2009140436A2 Guanylyl cyclase c qrt-pcr
11/19/2009WO2009140432A2 Micelles for intracellular delivery of therapeutic agents
11/19/2009WO2009140421A2 Polymeric carrier
11/19/2009WO2009140394A1 Separation of rebaudioside a from stevia glycosides using chromatography
11/19/2009WO2009140342A1 Glucagon receptor antagonists, compositions, and methods for their use
11/19/2009WO2009140341A2 Atorvastatin compositions
11/19/2009WO2009140320A1 Pyrrolopyridines as kinase inhibitors
11/19/2009WO2009140287A1 Salinosporamide derivatives as proteasome inhibitors
11/19/2009WO2009140279A2 Sulfonyl urea compounds
11/19/2009WO2009140275A1 Analogs of propofol, preparation thereof and use as anesthetics
11/19/2009WO2009140265A2 Methods and compositions for the treatment of obesity
11/19/2009WO2009140260A2 Cancer stem cell immortalization
11/19/2009WO2009140215A2 Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
11/19/2009WO2009140204A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009WO2009140201A1 Methods for preventing the development of retinopathy by the oral administration of nnr ligands
11/19/2009WO2009140200A1 Compounds for improving learning and memory
11/19/2009WO2009140164A1 6-aminonicotinamide derivatives as potent and selective histone deacetylase inhibitors
11/19/2009WO2009140163A1 Oxazolobenzimidazole derivatives
11/19/2009WO2009140144A1 Forms of crystalline lapatinib and processes for preparation thereof
11/19/2009WO2009140138A1 Quinolynylmethylimidizoles as therapeutic agents
11/19/2009WO2009140137A1 Naphthylmethylimidizoles for the treatment of stress urinary incontinence
11/19/2009WO2009140131A2 Compliant composites for application of drug-eluting coatings to tissue surfaces
11/19/2009WO2009140128A2 Compounds and compositions as kinase inhibitors
11/19/2009WO2009140111A1 Angiotensin ii receptor antagonists
11/19/2009WO2009140105A2 Formulations for cathepsin k inhibitors
11/19/2009WO2009140101A2 Imidazopyridine compounds useful as mmp-13 inhibitors
11/19/2009WO2009140078A1 Treatment of lower urinary tract dysfunction with cb2-receptor-selective agonists
11/19/2009WO2009140059A2 Narcotic emulsion formulations for treatment of surgical pain
11/19/2009WO2009140043A2 Ocular imaging system
11/19/2009WO2009139948A1 Poly aromatic sodium channel blockers
11/19/2009WO2009139925A1 Methods for the treatment of brain edema
11/19/2009WO2009139924A2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
11/19/2009WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity
11/19/2009WO2009139901A2 Methods and compositions for improving cognitive function
11/19/2009WO2009139888A1 Oral formulations of cytidine analogs and methods of use thereof
11/19/2009WO2009139886A2 Targeting an hiv-1 nef-host cell kinase complex
11/19/2009WO2009139880A1 Thioxoisoindoline compounds and compositions and methods of using the same
11/19/2009WO2009139876A2 Regenerating and enhancing development of muscle tissue
11/19/2009WO2009139870A1 Oxo-imidazolyl compounds having antibacterial activity
11/19/2009WO2009139834A1 Bioactive compounds for treatment of cancer and neurodegenerative diseases
11/19/2009WO2009139817A2 Crystalline pharmaceutical and methods of preparation and use thereof
11/19/2009WO2009139766A1 Anticancer combination therapy including triciribine
11/19/2009WO2009139710A1 Quinuclidine derivatives and their use as muscarinic receptor antagonists
11/19/2009WO2009139709A1 Quinuclidine derivatives and their use as muscarinic receptor antagonists for the treatment of asthma and chronic obstructive pulmonary disease (copd)
11/19/2009WO2009139708A1 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
11/19/2009WO2009139707A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
11/19/2009WO2009139511A1 A composition for regulation cellular senescence comprising lysophosphatidic acid and inhibitor of adenylyl cyclase as active ingredients
11/19/2009WO2009139504A2 A solid pharmaceutical formulation
11/19/2009WO2009139470A1 Pharmaceutical composition for treatment of fibromyalgia
11/19/2009WO2009139468A1 Coccidiosis control agent and feed containing the same
11/19/2009WO2009139411A1 Transdermal preparation containing palonosetron
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139362A1 Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009139343A1 Antitumor agent, kit and method of treating cancer
11/19/2009WO2009139340A1 Pyrazole compound
11/19/2009WO2009139231A1 Extract produced from orchid family plant, method for production thereof, and preparation for external application to skin comprising extract produced from orchid family plant
11/19/2009WO2009139213A1 Pharmaceutical composition for external application containing prochlorperazine
11/19/2009WO2009139181A1 10a-azalide compound having 4-membered ring structure
11/19/2009WO2009139168A1 Therapeutic agent for pain
11/19/2009WO2009139156A1 Therapeutic agent for male sterility
11/19/2009WO2009139085A1 Antitumor agent, kit, and method for treating cancer
11/19/2009WO2009139076A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009WO2009139004A2 Tat dna sequences, gene constructs, vaccine and processes thereof
11/19/2009WO2009138884A2 Compositions and methods for inhibiting gastric acid secretion
11/19/2009WO2009138847A2 An improved process for the preparation of cefozopran
11/19/2009WO2009138843A1 Glycosaminoglycan oral use and compositions
11/19/2009WO2009138806A1 Novel liposome cocktail formulations containing doxorubicin and the potent multidrug resistance inhibitor amiodarone
11/19/2009WO2009138802A1 A drilling rig and a method for moving a drilling rig
11/19/2009WO2009138799A1 Therapeutic uses of 1-cycl0pr0pyl-3 - [3- ( 5 -morpholin- 4 -ylmethyl- 1h-benz0imidaz0l- 2 -yl) -lh-pyrazol-4-yl] -urea
11/19/2009WO2009138796A2 Substituted quinazolines
11/19/2009WO2009138795A1 Substituted quinazolines
11/19/2009WO2009138794A1 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases
11/19/2009WO2009138793A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009WO2009138792A1 Substituted quinazolines
11/19/2009WO2009138791A1 2h- pyrimido [2, 1-b] quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents
11/19/2009WO2009138790A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
11/19/2009WO2009138789A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009WO2009138788A1 Substituted quinazolines
11/19/2009WO2009138781A1 Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
11/19/2009WO2009138780A2 Therapeutic treatment - 355
1 ... 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 ... 7860